Artelo Biosciences, Inc.
ARTL
$7.16
-$0.15-2.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 600.00K | 1.72M | 2.07M | 746.00K | 2.34M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 95.00K | 107.00K | 167.00K | 212.00K | 219.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 424.00K | -- |
| Total Current Assets | 695.00K | 1.83M | 2.23M | 1.38M | 2.56M |
|
|
|||||
| Total Current Assets | 695.00K | 1.83M | 2.23M | 1.38M | 2.56M |
| Net Property, Plant & Equipment | 64.00K | 73.00K | 82.00K | 91.00K | 99.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.00K | 328.00K | 3.00K | 3.00K | 3.00K |
| Total Assets | 2.80M | 4.27M | 4.36M | 3.52M | 4.70M |
|
|
|||||
| Total Accounts Payable | 3.04M | 3.87M | 4.84M | 2.51M | 1.68M |
| Total Accrued Expenses | 359.00K | 78.00K | 44.00K | 23.00K | 61.00K |
| Short-term Debt | 609.00K | 875.00K | 791.00K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 40.00K | 39.00K | 36.00K | 36.00K | 35.00K |
| Total Finance Division Other Current Liabilities | 1.00K | -- | -- | 236.00K | -- |
| Total Other Current Liabilities | 1.00K | -- | -- | 236.00K | -- |
| Total Current Liabilities | 4.04M | 4.86M | 5.71M | 2.80M | 1.77M |
|
|
|||||
| Total Current Liabilities | 4.04M | 4.86M | 5.71M | 2.80M | 1.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 609.00K | 875.00K | 791.00K | -- | -- |
| Capital Leases | 29.00K | 40.00K | 51.00K | 59.00K | 69.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.07M | 4.90M | 5.76M | 2.86M | 1.84M |
|
|
|||||
| Common Stock & APIC | 62.02M | 58.49M | 54.62M | 53.39M | 53.20M |
| Retained Earnings | -63.02M | -58.85M | -55.73M | -52.51M | -50.14M |
| Treasury Stock & Other | -272.00K | -277.00K | -295.00K | -227.00K | -202.00K |
| Total Common Equity | -1.27M | -633.00K | -1.41M | 652.00K | 2.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.27M | -633.00K | -1.41M | 652.00K | 2.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.27M | -633.00K | -1.41M | 652.00K | 2.86M |
|
|
|||||